Your browser doesn't support javascript.
loading
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Somersan-Karakaya, Selin; Mylonakis, Eleftherios; Mou, Jenni; Oviedo-Orta, Ernesto; O'Brien, Meagan P; Mas Casullo, Veronica; Mahmood, Adnan; Hooper, Andrea T; Hussein, Mohamed; Ali, Shazia; Marty, Francisco M; Forleo-Neto, Eduardo; Bhore, Rafia; Hamilton, Jennifer D; Herman, Gary A; Hirshberg, Boaz; Weinreich, David M.
Afiliação
  • Somersan-Karakaya S; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Mylonakis E; Division of Infectious Diseases, Brown University, Providence, Rhode Island, USA.
  • Mou J; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Oviedo-Orta E; Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • O'Brien MP; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Mas Casullo V; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Mahmood A; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Hooper AT; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Hussein M; Medical Affairs, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Ali S; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Marty FM; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Forleo-Neto E; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Bhore R; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Hamilton JD; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Herman GA; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Hirshberg B; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
  • Weinreich DM; Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA.
Open Forum Infect Dis ; 10(5): ofad211, 2023 May.
Article em En | MEDLINE | ID: mdl-37229174
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos